Abstract
Colorectal cancer is one of the most prevalent cancer types in the world, with annual incidence estimated in 1.200.000 new cases and mortality estimated in 609.000 victims. Unfortunately, 20% of patients with colorectal cancer are diagnosed with advanced metastatic disease, and the 5-year overall survival rate for this patients is 12%. Despite the new therapeutic options based on the use …